Calton & Associates’s Global Blood Therapeutics, Inc. GBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-6,016
| Closed | -$409K | – | 291 |
|
|
2022
Q3 | $409K | Buy |
+6,016
| New | +$409K | 0.23% | 108 |
|
|
2022
Q2 | – | Sell |
-6,321
| Closed | -$218K | – | 367 |
|
|
2022
Q1 | $218K | Sell |
6,321
-4,097
| -39% | -$141K | 0.06% | 319 |
|
|
2021
Q4 | $304K | Sell |
10,418
-2,278
| -18% | -$66.5K | 0.08% | 256 |
|
|
2021
Q3 | $323K | Buy |
12,696
+6,610
| +109% | +$168K | 0.07% | 278 |
|
|
2021
Q2 | $219K | Sell |
6,086
-102
| -2% | -$3.67K | 0.04% | 367 |
|
|
2021
Q1 | $252K | Sell |
6,188
-100
| -2% | -$4.07K | 0.05% | 322 |
|
|
2020
Q4 | $272K | Buy |
6,288
+593
| +10% | +$25.7K | 0.05% | 286 |
|
|
2020
Q3 | $314K | Buy |
5,695
+265
| +5% | +$14.6K | 0.06% | 230 |
|
|
2020
Q2 | $343K | Sell |
5,430
-5
| -0.1% | -$316 | 0.07% | 202 |
|
|
2020
Q1 | $278K | Buy |
5,435
+2,429
| +81% | +$124K | 0.07% | 217 |
|
|
2019
Q4 | $239K | Buy |
+3,006
| New | +$239K | 0.05% | 301 |
|